Abstract

Feline Transdermal Formulation Considerations

Author(s): Forsythe Lauren Eichstadt

Issue: Nov/Dec 2017 - Volume 21, Number 6

Page(s): 446-452

Download in electronic PDF format for $75

Abstract

Transdermal delivery of drugs is comparatively new in feline patients. However, transdermal formulations can be a desirable option for treating feline patients that are not willing participants to medication administration. However, achieving drug penetration across the skin is not always easy, and there are a wide variety of variables that can further affect penetration. This, coupled with a lack of studies, make transdermal administration an unknown with regards to efficacy and safety for many drugs. This article focuses on drugs that are administered transdermally with the intent of producing systemic effects.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Nov/Dec 2014 Pg. 512-515	In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Sep/Oct 2013 Pg. 370-374	Chemical Penetration Enhancers Author(s): Newton Stephen J
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D